| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/22/2008 | US7402657 C-C chemokine receptor 3 proteins |
| 07/22/2008 | US7402655 Nucleotide sequences coding polypeptide for use in the treatment of canccer, inflamation and infectious disorders |
| 07/22/2008 | US7402609 Olopatadine formulations for topical administration |
| 07/22/2008 | US7402605 E.g., 17,17-propano-16-hydroxy-5-(4-ethoxycarbonylthiazol-2-yl)-9-oxo-1,2,3,4,20-pentanor-5-thia-8-azaprost-13-ene; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder |
| 07/22/2008 | US7402601 ADMINISTERING A DRUG CONTAINING N-(4-TRIFLUOROMETHYLphenyl)-5-METHYLISOXAZOLE-4-CARBOXANILIDE or N-(4-TRIFLUOROMETHYLPHENYL)-2-CYANO-3-HYDROXYCROTONAMIDE; antiinflammatory agents, immunomodulators, immunosuppressants |
| 07/22/2008 | US7402580 Polymerase inhibitors; antiischemic agents; brain disorders; cardiovascular disorders; antiinflammatory agents; antiarthritic agents; neurodegenerative agents; Alzheimer's disease; muscular disorders; antidiabetic agents; kidney disorders; viricides; anticancer agents; immunosuppressants |
| 07/22/2008 | US7402577 Androstane 17-beta-carboxamides as androgen receptor modulators |
| 07/22/2008 | US7402572 Suppressing a symptom of an allergic response using nucleic acids containing unmethylated CpG dinucleotides |
| 07/22/2008 | US7402563 EPF derived peptides and therapeutic compositions |
| 07/22/2008 | US7402430 Preparing synthetic antigen presenting matrix/biological scaffold comprising immobilized major histocompatibility complex for use in identifying modulator for treatment and prevention of autoimmune, allergy and cancer disorders |
| 07/22/2008 | US7402410 Humanized immunoglobulin reactive with α4β7 integrin |
| 07/22/2008 | US7402324 Process for preparing aqueous extracts of plants and extracts so obtained |
| 07/22/2008 | US7402305 Comprises nucleotide sequences coding protein with antiproliferative and viricidal activity for use in treatment and prevention of cancer, nervous system, bone and autoimmune disorders |
| 07/22/2008 | US7402304 human granulocyte colony stimulating factor polypeptides having amino acid replacements in the sequence, used for treating hematopoietic, neurological or reproductive disorders |
| 07/22/2008 | CA2417825C 6.alpha., 9.alpha.-difluoro-17.alpha.-`(2-furanylcarboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 07/22/2008 | CA2384418C Use of cytokines, cells, and mitogens to inhibit graft versus host disease |
| 07/22/2008 | CA2283420C Lyme disease antigen compositions and uses |
| 07/22/2008 | CA2238661C Killer t cell activator and use thereof |
| 07/22/2008 | CA2196801C Novel vaccine adjuvant and vaccine |
| 07/22/2008 | CA2017025C Tumor necrosis factor binding protein ii, its purification and antibodies thereto |
| 07/19/2008 | CA2574531A1 Hat acetylation promoters and uses of compositions thereof in promoting immunogenicity |
| 07/17/2008 | WO2008086395A2 Anti-il-13 antibody formulations and uses thereof |
| 07/17/2008 | WO2008085008A1 T-cell inhibiting compounds and their use for the treatment of t-cell-mediated diseases |
| 07/17/2008 | WO2008084864A1 Capsaicin receptor activator and apparatus for spraying the same |
| 07/17/2008 | WO2008084861A1 Condensed pyridine compound |
| 07/17/2008 | WO2008055206A9 Humanized anti-factor d antibodies |
| 07/17/2008 | WO2008049011A3 Alpha-msh therapies for treatment of autoimmune disease |
| 07/17/2008 | WO2008023278A3 1alpha-hydroxy-2- (3 ' -hydroxypropylidene) -19-n0r- vitamin d compounds with a 1,1-dimethylpropyl side chain |
| 07/17/2008 | WO2007073177A3 Composition comprising polyunsaturated fatty acids for improving membrane composition |
| 07/17/2008 | US20080171882 [(4S)-4-Methyl-2,5-dioxoimidazolidin-4-yl]methanesulfonyl chloride and [(4R)-4-methyl-2,5-dioxoimidazolidin-4-yl]methanesulfonyl chloride; chemical intermediates for enzyme inhibitors |
| 07/17/2008 | US20080171850 Isomeric mixture of a cyclosporine analogue modified at the 1-amino acid residue with a 1,3-diene substituent; antiinflammatory agents; autoimmune disease; side effect reduction; reduced toxicity |
| 07/17/2008 | US20080171782 2-[5-(3-Methylphenyl)-1-octyl-1H-indol-3-yl]acetamide (cysmethynil) and derivatives; anticarcinogenic agents; leukemia; antiinflammatory agents; multiple sclerosis, antiarthritic agents; rheumatic diseases;osteoporosis, stroke, asthma; glaucoma; screening; catalyzed CaaX protein methylation |
| 07/17/2008 | US20080171763 Compounds and methods for treatment and prevention of diseases |
| 07/17/2008 | US20080171729 For an antiinflammatory agent, antiacne agent, antiproliferative agent, antiphototoxic agent, anti-hair loss agent, analgesic, antiaging agent, antiperspirant, antipruritic, astringent, or microbiocide; calcineurin inhibitors |
| 07/17/2008 | US20080171711 One mRNA contains a domain coding for a tumor antigen and one mRNA contains a domain coding for an immunogenic protein; genetic vaccines; gene therapy; improved stability |
| 07/17/2008 | US20080171688 And for use in the serological diagnosis of Varicella-Zoster virus infections; lower risk than vaccines from attenuated viable viruses |
| 07/17/2008 | US20080171106 Exposing probiotic to a gastric juice; providing a model of a pet small intestine;introducing the probiotic and a pathogen into the model;measuring anti-pathogenic metabolite produced by probiotic; andusing the identified probiotic to produce a pet food |
| 07/17/2008 | US20080171082 Pharmaceutically acceptable phosphate-glycerol carrying bodies |
| 07/17/2008 | US20080171081 Administering liposomes carrying phosphate-glycerol groups; inhibiting and/or reducing the progression of the T-cell function-mediated disorder; antiinflammatory |
| 07/17/2008 | US20080171066 Non-pathogenic Bacillus spores comprising a polynucleotide sequence encoding a phagosome membrane-rupturing agent; and a polynucleotide sequence encoding a heterologous polypeptide; immunisation and vaccination |
| 07/17/2008 | US20080171060 Lymphocyte receptor peptide for use in prevention and treatment of viral infection, cell proliferative, cardiovascular and allergic disorders; enhancing cytokine production |
| 07/17/2008 | US20080171059 Using transgenic cells expressing cancer antigen fusion as inducer of cell-mediated immune response targeting tumor cells; immunotherapy |
| 07/17/2008 | US20080171057 Using proteomic profiles as diagnostic indicators of metabolic disorders; bioinformatics |
| 07/17/2008 | US20080171049 For prophylaxis and therapy of hemorrhagic virus infection, autoimmune diseases, autograft rejection, neoplasm, hyperhomocysteineuria, cardiovascular disease, stroke, Alzheimer's disease, or diabetes; can be used in combination with an anti-hemorrhagic viral infection agent, an immunosuppressant; kits |
| 07/17/2008 | US20080171047 Preventing tissue rejection by administering patient immunoglobulin which reduces integrin alpha E, transforming growth factor and cadherin E expression |
| 07/17/2008 | US20080171046 Novel proteins and nucleic acids encoding same |
| 07/17/2008 | US20080171036 Using tumor necrosis factor specific immuoglobulin for diagnosis, treatment and prevention of inflammatory, cell proliferative, skin, respiratory system, nervous system and infectious disorders |
| 07/17/2008 | US20080171033 Dipeptidyl peptidase-4 (DPP-4) (CD26) for use in treating diabetic retinopathy, psoriasis and arthritis; cytokine inhibition of interleukin-1 activity |
| 07/17/2008 | US20080171023 Nutrient broth comprising nervous system tissue is exposed to tumor associated antigen in order to ellicit enhanced CD8+T cell response; administered to cancer patient to treat cell proliferative disorders; immunotherapy |
| 07/17/2008 | US20080171021 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
| 07/17/2008 | US20080171014 Interleukin-13 binding proteins |
| 07/17/2008 | US20080171002 Immunostimulants; free of storage protein from nongerminated seeds of Ricinus communis (Castor bean); treating cancer, infections, and pathogenic diseases; AM3 as example; binds to dendritic cell (DC)-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin (DC-SIGN) |
| 07/17/2008 | DE202007003266U1 Pharmazeutische Zusammensetzung zum Schutz vor Allergien und entzündlichen Erkrankungen Pharmaceutical composition for protection against allergies and inflammatory diseases |
| 07/17/2008 | DE102007001521A1 Verwendung von Cohn-Oncley-Fraktionen II und II/III zur Behandlung des systemischen Lupus erythematodes Using Cohn-Oncley fractions II and II / III for the treatment of systemic lupus erythematosus |
| 07/17/2008 | CA2675288A1 Condensed pyridine compound |
| 07/16/2008 | EP1944292A1 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents |
| 07/16/2008 | EP1944043A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 07/16/2008 | EP1944033A2 Use of pectin hydrolysis products |
| 07/16/2008 | EP1942943A2 Peptide-dicer substrate rna conjugates as delivery vehicles for sirna |
| 07/16/2008 | EP1942925A2 Methods for fusion polypeptide delivery into a cell |
| 07/16/2008 | EP1942889A2 Use of bipyridine compound 'caerulomycin a' derivatives and analogs thereof as immunosuppressive agents |
| 07/16/2008 | EP1499325B1 Composition comprising trehalose and zinc and use thereof to inhibit skin irritation |
| 07/16/2008 | EP1476541B1 Cytokine (zcytor17 ligand) |
| 07/16/2008 | EP1471907B1 Use of c-kit inhibitors for treating autoimmune diseases |
| 07/16/2008 | EP1392264B1 Delivery of antiemetics through an inhalation route |
| 07/16/2008 | EP1392257B1 Delivery of antihistamines through an inhalation route |
| 07/16/2008 | EP1318835B1 Use of imidazoquinolinamines as adjuvants in dna vaccination |
| 07/16/2008 | EP1311542B1 Tolerogenic peptides |
| 07/16/2008 | EP1305006B1 Process for the manufacture of dispersions for formulating slightly or poorly soluble active ingredients |
| 07/16/2008 | EP1265603B1 Il-8 receptor antagonists |
| 07/16/2008 | EP1090122B1 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses |
| 07/16/2008 | EP1054004B1 Novel pyrimidine-5-carboxamide derivatives |
| 07/16/2008 | EP0951551B1 Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily |
| 07/16/2008 | CN101223168A Heterocyclic JANUS kinase 3 inhibitors |
| 07/16/2008 | CN101223162A Indolylmaleimide derivatives |
| 07/16/2008 | CN101223160A Benzoimidazole compound capable of inhibiting prostaglandin D synthetase |
| 07/16/2008 | CN101222941A A method for preparing a stable immunogenic product comprising antigenic heterocomplexes of TNF alpha and a carrier protein |
| 07/16/2008 | CN101220361A Representation method for recombinant american cockroaches allergen protein |
| 07/16/2008 | CN101220091A Yao horsefly salivary gland immunoregulation peptide, gene and application thereof |
| 07/16/2008 | CN101220028A Urea substituted imidazopyridines |
| 07/16/2008 | CN101219985A N-substituted indole-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action |
| 07/16/2008 | CN101219217A Adjuvant composition and methods for its use |
| 07/16/2008 | CN101219154A Microorganism additive agent for improving phylactic power of pets and accelerating growth |
| 07/16/2008 | CN101219147A Dectancyl mastication tablet for dogs and cats |
| 07/16/2008 | CN101219131A Method for applying calcium polyenoic acid for medical and beauty treatment fields |
| 07/16/2008 | CN100402555C White fungus heteropolysaccharide and its extract, preparation method and uses |
| 07/16/2008 | CN100402528C Urea substituted imidazopyridines |
| 07/16/2008 | CN100402496C Compounds useful as matrix metalloprotease inhibitors |
| 07/16/2008 | CN100402085C Production of high-concentration thymic peptide solution and large-specification thymic peptide preparation |
| 07/16/2008 | CN100402031C Parenteral formulations containing a rapamycin hydroxyester |
| 07/16/2008 | CN100402024C Gingko lactone freeze dried powder injection and its preparation method |
| 07/15/2008 | US7399901 linker for activation of T- cells (lat genes and proteins), used for screening drug useful for treatment against asthma and allergies |
| 07/15/2008 | US7399878 Pharmaceutical compounds |
| 07/15/2008 | US7399849 Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof |
| 07/15/2008 | US7399829 Variants of RANKL protein |
| 07/15/2008 | US7399827 For diagnosis and for vaccine based therapy of neoplasms of prostate, testis and uterus; inhibiting the growth of malignant cells expressing PAGE-4, and methods of inducing an enhanced immune response to PAGE-4-expressing cancers |
| 07/15/2008 | US7399763 and highly specific HIV replication inhibitor; ethyl 2-benzyl-8-hydroxy-1-oxo-1,2,3,4-tetrahydropyrrolo[1,2- alpha ]pyrazine-7-carboxylate; aquired immune deficiency syndrome (AIDS) |
| 07/15/2008 | US7399756 Organo-phosphorous compounds for activating gamma/delta T cells |
| 07/15/2008 | US7399472 Vaccines |
| 07/15/2008 | US7399464 Polypeptides of the IFNα-7 gene |